Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) FCF Margin (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed FCF Margin for 6 consecutive years, with 562.07% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 97197.0% to 562.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1006.82% through Dec 2025, up 38355.0% year-over-year, with the annual reading at 1006.82% for FY2025, 38355.0% up from the prior year.
  • FCF Margin for Q4 2025 was 562.07% at Caribou Biosciences, up from 1080.85% in the prior quarter.
  • The five-year high for FCF Margin was 1279.38% in Q1 2021, with the low at 1820.55% in Q3 2024.
  • Average FCF Margin over 5 years is 818.2%, with a median of 882.02% recorded in 2021.
  • The sharpest move saw FCF Margin crashed -212007bps in 2022, then soared 97197bps in 2025.
  • Over 5 years, FCF Margin stood at 908.25% in 2021, then rose by 24bps to 690.95% in 2022, then tumbled by -32bps to 911.64% in 2023, then plummeted by -68bps to 1534.04% in 2024, then soared by 63bps to 562.07% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 562.07%, 1080.85%, and 1109.97% for Q4 2025, Q3 2025, and Q2 2025 respectively.